Stockreport

Design Therapeutics GAAP EPS of -$0.23 beats by $0.02 [Seeking Alpha]

Design Therapeutics, Inc.  (DSGN) 
PDF Cash, cash equivalents and marketable securities were $254.1 million as of September 30, 2024, which the company expects to fund its planned operating expenses into 202 [Read more]